TVTX: Travere Therapeutics, Inc. Stock

by  •  • Comments Off on TVTX: Travere Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 482.66
Enterprise Value ($M) 817.10
Book Value ($M) 74.07
Book Value / Share 0.97
Price / Book 6.52
NCAV ($M) -108.40
NCAV / Share -1.42
Price / NCAV -4.45

Profitability (mra)
Return on Invested Capital (ROIC) -0.34
Return on Assets (ROA) -0.20
Return on Equity (ROE) -0.85

Liquidity (mrq)
Quick Ratio 2.75
Current Ratio 2.78

Balance Sheet (mrq) ($M)
Current Assets 481.08
Assets 663.55
Liabilities 589.48
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 145.24
Operating Income -376.74
Net Income -111.40
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -280.02
Cash from Investing 55.78
Cash from Financing 218.75

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-01 13G Rock Springs Capital Management LP 5.79
02-14 13G/A Armistice Capital, Llc 9.83 15.16
02-14 13G/A Macquarie Group Ltd 6.31 33.47
02-14 13G/A Deep Track Capital, LP 9.99 64.17
02-13 13G/A Vanguard Group Inc 7.34 56.88
02-12 13G/A Janus Henderson Group Plc 0.00 -99.37
02-09 13G Morgan Stanley 5.50
02-07 13G/A Adage Capital Partners Gp, L.l.c. 0.67 -88.69
01-25 13G/A State Street Corp 7.12 26.71
01-24 13G/A BlackRock Inc. 10.60 3.74
2023-05-15 13G/A Ra Capital Management, L.p. 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-14 133,358 905,440 14.73
2024-05-13 77,038 552,997 13.93
2024-05-10 89,317 407,961 21.89
2024-05-09 102,927 568,838 18.09

(click for more detail)

Similar Companies
TRDA – Entrada Therapeutics, Inc. TRVI – Trevi Therapeutics, Inc.
TSBX – Turnstone Biologics Corp. URGN – UroGen Pharma Ltd.
VCEL – Vericel Corporation


Financial data and stock pages provided by
Fintel.io